Medical Condition News

RSS

Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative study in the journal npj Precision Oncology.

4 Aug 2026

New 3D brain tissue model accelerates Alzheimer's drug development

How can Alzheimer's research be made faster, better, and more effective? After decades of intensive research worldwide and despite recent therapeutic advances, scientists have not managed to fully arrest the progress of the disease.

4 Aug 2026

Study connects late-life psychosis to abnormal tau protein buildup

Hallucinations and delusions that appear for the first time in midlife or later are often treated as psychiatric symptoms whose biological cause is unclear.

4 Aug 2026

Researchers suggest a potential therapeutic strategy for muscle loss associated with obesity

Obesity has been linked to skeletal muscle loss and deterioration. While M2 macrophages may play a role in regulating muscle function, the underlying mechanisms remain poorly understood.

4 Aug 2026

New gum disease treatment kills harmful bacteria while saving beneficial microbes

Researchers at Nagoya University in Japan have created an innovative treatment for periodontitis that targets and eliminates harmful bacteria while preserving beneficial oral microbes essential for health.

4 Aug 2026

New genomic approach links rare immune cells to autoimmune disease risk

Much of how genetic risk leads to disease has remained hidden. In many cases, genetic variants linked to disease do not act on nearby genes along the chromosome.

4 Aug 2026

Continuous glucose monitors show no proven benefits for healthy people

Continuous glucose monitors are becoming increasingly popular, including among people without diabetes.

4 Aug 2026

Sino Biological launches precisely characterized full-length p-Tau217 protein to advance next-generation Alzheimer’s Biomarker assay development

Sino Biological Inc. is pleased to announce the launch of its Recombinant Human p-Tau217 Protein (Cat. No. T08-50SN), a full-length, tag-free Tau reagent developed to support Alzheimer’s disease biomarker assay development, antibody evaluation, and Tau biology research.

From Sino Biological Inc. 4 Aug 2026

Study links lower vitamin D to mood and cognitive health in adults over 85 with diabetes

Researchers studying 188 adults aged 85 years or older with type 2 diabetes found the lowest serum 25(OH)D concentrations among those with both depressive symptoms and mild cognitive impairment. Lower levels remained associated with having both conditions after adjustment for selected factors, but the cross-sectional study cannot establish causation or a benefit from supplementation.

3 Aug 2026

Review explores mechanisms driving cardiovascular aging and disease risk

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Aging is an inevitable biological process marked by progressive functional decline and elevated risk of cardiovascular diseases (CVDs).

3 Aug 2026

Broader autism definition may lead to confusion and possible misdiagnosis

The definition of autism may have become so wide that it risks confusion and even misdiagnosis, according to a new editorial by UCL Professor Dame Uta Frith, whose pioneering research in the 1960s and 70s lay the foundations for how we understand autism.

3 Aug 2026

Advances in X chromosome inactivation open therapeutic opportunities for X-linked genetic disorders

A new review explores how advances in understanding X chromosome inactivation (XCI) are creating potential therapeutic opportunities for a range of X-linked genetic disorders, including Rett syndrome, Fabry disease, Duchenne muscular dystrophy, hemophilia, and others.

3 Aug 2026

Texas A&M study links polyethylene microplastics to fatty liver disease

Microplastics have become nearly impossible to avoid. They have been detected in oceans, drinking water and even the human body, but scientists are still uncovering how they affect human health.

3 Aug 2026

Study of lung immune cells uncovers roots of autoimmune disease

A massive analysis of immune cells in human tissue is yielding clues to the root cause of lung and autoimmune diseases.

3 Aug 2026

New blood marker could help track MS progression and monitor treatment response

Modern therapies have transformed care for people with multiple sclerosis (MS). Yet the disease continues to progress in a substantial proportion of patients, even in the absence of relapses.

3 Aug 2026

Digital twin of the gut-brain axis aims to advance neurostimulation therapies

The gut and brain are in constant conversation, exchanging signals that regulate hunger and digestion, as well as the body's response to stress.

3 Aug 2026

Using DNA sequencing for accurate identification of microbial infections in cystic fibrosis patients

Lung infections are a constant risk for people living with cystic fibrosis (CF), a life-threatening genetic disorder which impairs lung function, predisposes people to persistent airway infections and exposes them to acquiring multidrug resistant infections.

3 Aug 2026

AI model can use routine sleep study data to identify patients' long-term health risks

A novel AI model can use information collected during routine sleep studies to identify patients' long-term health risks, according to a new study published in Nature Communications.

3 Aug 2026

Study shows effectiveness of surgical treatment for chronic rhinosinusitis with nasal polyps

Both full and limited endoscopic sinus surgery significantly improve quality of life in patients with chronic rhinosinusitis with nasal polyps, according to a recent study published in Allergy.

3 Aug 2026

Gut microbiome shifts may begin before Alzheimer’s symptoms appear

A narrative review links reduced SCFA-producing gut bacteria and altered microbial metabolism with Alzheimer’s disease, while early evidence suggests similar changes may appear before cognitive symptoms. Mediterranean, DASH, MIND, and prudent diets are associated with beneficial microbial profiles, but direct evidence connecting diet, the microbiome, and amyloid pathology remains limited.

3 Aug 2026

Medical Condition News

Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer

New 3D brain tissue model accelerates Alzheimer's drug development

Study connects late-life psychosis to abnormal tau protein buildup

Researchers suggest a potential therapeutic strategy for muscle loss associated with obesity

New gum disease treatment kills harmful bacteria while saving beneficial microbes

New genomic approach links rare immune cells to autoimmune disease risk

Continuous glucose monitors show no proven benefits for healthy people

Sino Biological launches precisely characterized full-length p-Tau217 protein to advance next-generation Alzheimer’s Biomarker assay development

Study links lower vitamin D to mood and cognitive health in adults over 85 with diabetes

Review explores mechanisms driving cardiovascular aging and disease risk

Broader autism definition may lead to confusion and possible misdiagnosis

Advances in X chromosome inactivation open therapeutic opportunities for X-linked genetic disorders

Texas A&M study links polyethylene microplastics to fatty liver disease

Study of lung immune cells uncovers roots of autoimmune disease

New blood marker could help track MS progression and monitor treatment response

Digital twin of the gut-brain axis aims to advance neurostimulation therapies

Using DNA sequencing for accurate identification of microbial infections in cystic fibrosis patients

AI model can use routine sleep study data to identify patients' long-term health risks

Study shows effectiveness of surgical treatment for chronic rhinosinusitis with nasal polyps

Gut microbiome shifts may begin before Alzheimer’s symptoms appear

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News